The Beckley Foundation is a UK-based non-profit dedicated to pioneering research into psychedelics and advocating for evidence-based drug policy reform. Founded by Amanda Feilding in 1998, the Foundation has been instrumental in bringing psychedelic science back into the mainstream—initiating groundbreaking studies on substances like psilocybin, LSD, and DMT in collaboration with leading global institutions.

Its mission is twofold: to scientifically explore the therapeutic potential of psychedelics for improving mental health and well-being, and to drive progressive changes in global drug policy that prioritize harm reduction, human rights, and public health.

5D Ventures has supported the Beckley Foundation philanthropically, aligning with its commitment to advancing research, responsible access, and the ethical integration of psychedelic medicine into society.